| 1 | A bill to be entitled |
| 2 | An act relating to animal control; amending s. |
| 3 | 381.0031, F.S.; requiring animal control officers, |
| 4 | wildlife officers, and disease laboratories to report |
| 5 | potential health risks to humans from animals; |
| 6 | amending s. 828.055, F.S.; providing for use of |
| 7 | additional prescription drugs for euthanasia and |
| 8 | chemical immobilization of animals; providing for |
| 9 | rulemaking to expand the list of additional |
| 10 | prescription drugs; providing that the Board of |
| 11 | Pharmacy or the Department of Health may revoke or |
| 12 | suspend a permit upon a determination that the |
| 13 | permittee or its employees or agents is using or has |
| 14 | used an authorized drug for other purposes or if a |
| 15 | permittee has committed specified violations; amending |
| 16 | s. 828.058, F.S.; restricting the use of intracardial |
| 17 | injection for euthanizing animals; prohibiting the |
| 18 | delivery of a lethal solution or powder by adding it |
| 19 | to food; providing an effective date. |
| 20 |
|
| 21 | Be It Enacted by the Legislature of the State of Florida: |
| 22 |
|
| 23 | Section 1. Section 381.0031, Florida Statutes, is amended |
| 24 | to read: |
| 25 | 381.0031 Report of diseases of public health significance |
| 26 | to department.- |
| 27 | (1) Any practitioner licensed in this state to practice |
| 28 | medicine, osteopathic medicine, chiropractic medicine, |
| 29 | naturopathy, or veterinary medicine; any hospital licensed under |
| 30 | part I of chapter 395; or any laboratory licensed under chapter |
| 31 | 483 that diagnoses or suspects the existence of a disease of |
| 32 | public health significance shall immediately report the fact to |
| 33 | the Department of Health. |
| 34 | (2) An animal control officer operating under s. 828.27, a |
| 35 | wildlife officer operating under s. 379.3311, or an animal |
| 36 | disease laboratory operating under s. 585.61 shall report |
| 37 | knowledge of any animal bite, diagnosis of disease in an animal, |
| 38 | or suspicion of a grouping or clustering of animals having |
| 39 | similar disease, symptoms, or syndromes that may indicate the |
| 40 | presence of a threat to humans. |
| 41 | (3)(2) Periodically The department shall periodically |
| 42 | issue a list of infectious or noninfectious diseases determined |
| 43 | by it to be a threat to public health and therefore of |
| 44 | significance to public health and shall furnish a copy of the |
| 45 | list to the practitioners listed in subsection (1). |
| 46 | (4)(3) Reports required by this section must be in |
| 47 | accordance with methods specified by rule of the department. |
| 48 | (5)(4) Information submitted in reports required by this |
| 49 | section is confidential, exempt from the provisions of s. |
| 50 | 119.07(1), and is to be made public only when necessary to |
| 51 | public health. A report so submitted is not a violation of the |
| 52 | confidential relationship between practitioner and patient. |
| 53 | (6)(5) The department may obtain and inspect copies of |
| 54 | medical records, records of laboratory tests, and other medical- |
| 55 | related information for reported cases of diseases of public |
| 56 | health significance described in subsection (3) (2). The |
| 57 | department shall examine the records of a person who has a |
| 58 | disease of public health significance only for purposes of |
| 59 | preventing and eliminating outbreaks of disease and making |
| 60 | epidemiological investigations of reported cases of diseases of |
| 61 | public health significance, notwithstanding any other law to the |
| 62 | contrary. Health care practitioners, licensed health care |
| 63 | facilities, and laboratories shall allow the department to |
| 64 | inspect and obtain copies of such medical records and medical- |
| 65 | related information, notwithstanding any other law to the |
| 66 | contrary. Release of medical records and medical-related |
| 67 | information to the department by a health care practitioner, |
| 68 | licensed health care facility, or laboratory, or by an |
| 69 | authorized employee or agent thereof, does not constitute a |
| 70 | violation of the confidentiality of patient records. A health |
| 71 | care practitioner, health care facility, or laboratory, or any |
| 72 | employee or agent thereof, may not be held liable in any manner |
| 73 | for damages and is not subject to criminal penalties for |
| 74 | providing patient records to the department as authorized by |
| 75 | this section. |
| 76 | (7)(6) The department may adopt rules related to reporting |
| 77 | diseases of significance to public health, which must specify |
| 78 | the information to be included in the report, who is required to |
| 79 | report, the method and time period for reporting, requirements |
| 80 | for enforcement, and required followup activities by the |
| 81 | department which are necessary to protect public health. |
| 82 | (8) This section does not affect s. 384.25. |
| 83 | Section 2. Section 828.055, Florida Statutes, is amended |
| 84 | to read: |
| 85 | 828.055 Controlled substances and legend drugs Sodium |
| 86 | pentobarbital; permits for use in euthanasia of domestic |
| 87 | animals.- |
| 88 | (1) The Board of Pharmacy shall adopt rules providing for |
| 89 | the issuance of permits authorizing the purchase, possession, |
| 90 | and use of sodium pentobarbital, and sodium pentobarbital with |
| 91 | lidocaine, tiletamine hydrochloride, alone or combined with |
| 92 | zolazepam (including Telazol), xylazine (including Rompun), |
| 93 | ketamine, acepromazine maleate (also acetylpromazine, and |
| 94 | including Atravet or Acezine), alone or combined with etorphine |
| 95 | (including Immobilon), and yohimbine hydrochloride, alone or |
| 96 | combined with atipamezole (including Antisedan) by county or |
| 97 | municipal animal control agencies or humane societies registered |
| 98 | with the Secretary of State for the purpose of euthanizing |
| 99 | injured, sick, or abandoned domestic animals which are in their |
| 100 | lawful possession or for the chemical immobilization of animals. |
| 101 | The rules shall set forth guidelines for the proper storage and |
| 102 | handling of these prescription drugs sodium pentobarbital and |
| 103 | sodium pentobarbital with lidocaine and such other provisions as |
| 104 | may be necessary to ensure that the drugs are used solely for |
| 105 | the purpose set forth in this section. The rules shall also |
| 106 | provide for an application fee not to exceed $50 and a biennial |
| 107 | renewal fee not to exceed $50. Upon formal, written request and |
| 108 | recommendation adopted in a public meeting by the Board of |
| 109 | Veterinary Medicine, the Board of Pharmacy may, by rule, add |
| 110 | controlled substances and legend drugs to the list of |
| 111 | prescription drugs in this subsection upon a finding that such |
| 112 | additions are necessary for the humane and lawful euthanasia of |
| 113 | injured, sick, or abandoned domestic animals or chemical |
| 114 | immobilization of animals. |
| 115 | (2) Any county or municipal animal control agency or any |
| 116 | humane society registered with the Secretary of State may apply |
| 117 | to the Department of Health Business and Professional Regulation |
| 118 | for a permit to purchase, possess, and use the prescription |
| 119 | drugs authorized under sodium pentobarbital or sodium |
| 120 | pentobarbital with lidocaine pursuant to subsection (1). Upon |
| 121 | certification by the Board of Pharmacy that the applicant meets |
| 122 | the qualifications set forth in the rules, the Department of |
| 123 | Health shall issue the permit. The possession and use of the |
| 124 | prescription drugs authorized under subsection (1) is limited to |
| 125 | those employees or agents of the permittee certified in |
| 126 | accordance with s. 828.058 or s. 828.27 while operating in the |
| 127 | scope of their respective official or employment duties with the |
| 128 | permittee. |
| 129 | (3) The department or the board may deny a permit, and |
| 130 | revoke, or suspend, or refuse to renew the permit of any |
| 131 | permittee, and may fine, place on probation, or otherwise |
| 132 | discipline any permittee, upon a determination that: |
| 133 | (a) The applicant or permittee or any of its employees or |
| 134 | agents is using or has used a prescription drug authorized under |
| 135 | subsection (1) sodium pentobarbital or sodium pentobarbital with |
| 136 | lidocaine for any purpose other than that set forth in this |
| 137 | section; or if the permittee fails to follow the rules of the |
| 138 | board regarding proper storage and handling. |
| 139 | (b) The applicant or permittee has failed to take |
| 140 | reasonable precautions against misuse, theft, loss, or diversion |
| 141 | of such prescription drugs; |
| 142 | (c) The applicant or permittee has failed to detect or to |
| 143 | report to the Department of Health a significant loss, theft, or |
| 144 | inventory shortage of such prescription drugs; |
| 145 | (d) The applicant or permittee has failed to follow the |
| 146 | rules of the Board of Pharmacy regarding proper storage and |
| 147 | handling of such prescription drugs; or |
| 148 | (e) The permittee has violated any provision of this |
| 149 | section, chapter 465, chapter 499, or any rule adopted under |
| 150 | those chapters. |
| 151 | (4) The Board shall adopt rules implementing subsection |
| 152 | (3), provided that disciplinary action may be taken only for a |
| 153 | substantial violation of the provisions of this section or the |
| 154 | rules adopted under this section. In determining the severity of |
| 155 | an administrative penalty to be assessed under this section, the |
| 156 | Department or the Board of Pharmacy shall consider: |
| 157 | (a) The severity of the violation; |
| 158 | (b) Any actions taken by the person to correct the |
| 159 | violation or to remedy complaints, and the timing of those |
| 160 | actions; and |
| 161 | (c) Any previous violations. |
| 162 | (5) The Department of Health may issue an emergency order |
| 163 | immediately suspending a permit issued under this section upon a |
| 164 | determination that a permittee, as a result of any violation of |
| 165 | any provision of this section or any rule adopted under this |
| 166 | section, presents a danger to the public health, safety, and |
| 167 | welfare. |
| 168 | (6) This section shall not apply to licensed pharmacies, |
| 169 | veterinarians, or health care practitioners operating within the |
| 170 | scope of the applicable professional act. |
| 171 | Section 3. Subsection (1) of section 828.058, Florida |
| 172 | Statutes, is amended to read: |
| 173 | 828.058 Euthanasia of dogs and cats.- |
| 174 | (1) Sodium pentobarbital, a sodium pentobarbital |
| 175 | derivative, or other agent the Board of Veterinary Medicine may |
| 176 | approve by rule shall be the only methods used for euthanasia of |
| 177 | dogs and cats by public or private agencies, animal shelters, or |
| 178 | other facilities which are operated for the collection and care |
| 179 | of stray, neglected, abandoned, or unwanted animals. A lethal |
| 180 | solution shall be used in the following order of preference: |
| 181 | (a) Intravenous injection by hypodermic needle; |
| 182 | (b) Intraperitoneal injection by hypodermic needle; |
| 183 | (c) If the dog or cat is unconscious with no corneal |
| 184 | reflex, intracardial injection by hypodermic needle; or |
| 185 | (d) Solution or powder added to food. |
| 186 | Section 4. This act shall take effect July 1, 2012. |